⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for epithelial ovarian

Every month we try and update this database with for epithelial ovarian cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)NCT02485990
Primary Periton...
Tremelimumab
Olaparib
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerNCT06173037
Primary Periton...
Fallopian Tube
Epithelial Ovar...
RC88
18 Years - RemeGen Co., Ltd.
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentNCT00421889
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Bladder Cancer
belinostat
Paclitaxel
Carboplatin
18 Years - Valerio Therapeutics
Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerNCT00501644
Ovarian Cancer
Fallopian Tube ...
Peritoneal Canc...
Carboplatin
GM-CSF (Sargram...
Interferon Gamm...
- M.D. Anderson Cancer Center
A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentNCT00421889
Ovarian Cancer
Epithelial Ovar...
Fallopian Tube ...
Bladder Cancer
belinostat
Paclitaxel
Carboplatin
18 Years - Valerio Therapeutics
ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaNCT00407407
Fallopian Tube ...
Peritoneal Neop...
Ovarian Neoplas...
ABI-007
Carboplatin
18 Years - Celgene
Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerNCT00501644
Ovarian Cancer
Fallopian Tube ...
Peritoneal Canc...
Carboplatin
GM-CSF (Sargram...
Interferon Gamm...
- M.D. Anderson Cancer Center
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)NCT02485990
Primary Periton...
Tremelimumab
Olaparib
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerNCT06173037
Primary Periton...
Fallopian Tube
Epithelial Ovar...
RC88
18 Years - RemeGen Co., Ltd.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: